FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.

J Med Virol · 2017 · PMC6139434 · PMID 27943311

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Even though this study was not powered to demonstrate a difference, there was also a numerical trend for patients treated with FV‐100 at either 200 mg or 400 mg to have a lower severity of pain than those treated with valacyclovir.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.